Netenax (Netilmicin)

Netilmicin, the active ingredient in Netenax, is an aminoglycoside antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial infections of the eye such as conjunctivitis, keratitis and blepharitis in patients requiring topical therapy.

GNH USA supplies Netenax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Netenax is an aminoglycoside antibiotic used to manage bacterial infections of the ocular surface and related structures.

- Bacterial conjunctivitis: reduces bacterial load and alleviates redness, discharge and discomfort. - Keratitis: eradicates pathogenic bacteria to promote corneal healing and preserve vision. - Blepharitis: controls bacterial overgrowth on the eyelid margin, reducing inflammation and crusting. - Other ocular bacterial infections: provides broad‑spectrum coverage for Gram‑negative and some Gram‑positive organisms affecting the eye.

Netenax may cause local ocular reactions and, rarely, systemic effects.

Common Side Effects: - Stinging or burning sensation upon instillation. - Temporary blurred vision. - Redness of the conjunctiva. - Mild itching or irritation. - Watery discharge. - Sensitivity to light.

Serious or Rare Side Effects: - Allergic contact dermatitis of the eyelid or peri‑ocular skin. - Corneal ulceration or epithelial defect. - Severe ocular inflammation or uveitis. - Systemic nephrotoxicity (rare with extensive use). - Ototoxicity (rare, especially with systemic absorption).

Before using Netenax, consider the following precautions.

- Assess renal function: adjust therapy if the patient has impaired renal clearance. - Monitor for hypersensitivity: discontinue if signs of allergic reaction appear. - Avoid use in viral or fungal eye infections: the drug is ineffective against non‑bacterial pathogens. - Limit duration: use only as prescribed to reduce risk of resistance. - Caution in pregnancy and lactation: benefits must outweigh potential risks. - Store at room temperature: keep in the original container, protect from light and moisture.

Netenax may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Concurrent systemic aminoglycosides: increased risk of nephrotoxicity and ototoxicity. - Neuromuscular blocking agents: may potentiate muscle weakness.

Moderate Interactions (Monitor Closely): - Topical anesthetic eye drops: may enhance corneal toxicity. - Corticosteroid eye preparations: may mask signs of infection. - Other topical antibiotics: assess for additive toxicity. - Preservatives in multi‑dose containers: monitor for irritation.